WO2024042007 - SUBSTITUTED BICYCLES AS HSET INHIBITORS

National phase entry:
Publication Number WO/2024/042007
Publication Date 29.02.2024
International Application No. PCT/EP2023/072876
International Filing Date 21.08.2023
Title **
[English] SUBSTITUTED BICYCLES AS HSET INHIBITORS
[French] BICYCLES SUBSTITUÉS UTILISÉS COMME INHIBITEURS DE HSET
Applicants **
MERCK PATENT GMBH
Inventors
BUCHSTALLER, Hans-Peter
KUHN, Daniel
COLLINS, Ian
MATTHEWS, Thomas
LANZ, Jan
SAINT-DIZIER, François
PREVET, Hugues
Priority Data
22191702.4   23.08.2022   EP
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3518
EPO Filing, Examination, Granting15508
Japan Filing, Examination, Granting2276
South Korea Filing, Examination, Granting2322
USA Filing, Examination, Granting8490
MasterCard Visa
Total: 32,114

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The invention relates to substituted bicycles of the general formula I, and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.[French] L'invention concerne des bicycles substitués de formule générale I, et l'utilisation des composés de la présente invention pour le traitement et/ou la prévention de maladies et de troubles hyperprolifératifs chez des mammifères, en particulier des êtres humains, et des compositions pharmaceutiques contenant un tel composé.

Rejoining the server...